Fresenius Medical Care AG & Co KGaA (FMS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Fresenius Medical Care AG & Co KGaA (FMS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012951
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:73
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Medical Care AG & Co KGaA (Fresenius Medical), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It is one of the largest kidney dialysis companies in the world. It provides dialysis care services and products to individuals with chronic kidney failure. It develops and manufactures a comprehensive range of dialysis machines, systems and disposable products. The company also offers Care Coordination services including pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It conducts its operations through its subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co KGaA (FMS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Fresenius Medical Care AG & Co KGaA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deal Details 12
Asset Purchase 12
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 12
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 14
Partnerships 15
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 15
Debiotech and Fresenius Medical Care Enter into Agreement 16
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 17
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 18
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 19
Debt Offering 20
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 20
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 21
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 22
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 23
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 25
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 26
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 27
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 28
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 29
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 30
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 31
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 32
Asset Transactions 33
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 33
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 34
Acquisition 35
Fresenius Medical Care to Acquire NxStage Medical for up to USD2 Billion 35
Fresenius Medical Care Acquires Xenios 37
Fresenius Medical Care to Acquire Nefrocontrol 38
Fresenius Medical Care AG & Co KGaA – Key Competitors 39
Fresenius Medical Care AG & Co KGaA – Key Employees 40
Fresenius Medical Care AG & Co KGaA – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Joint Venture 44
Recent Developments 45
Financial Announcements 45
Nov 02, 2017: Fresenius Medical Care delivers solid Q3 despite impact from natural disasters in North America 45
Aug 01, 2017: Fresenius Medical Care delivers another quarter of strong revenue growth 48
May 03, 2017: Fresenius Medical Care delivers strong first quarter 2017 50
Feb 22, 2017: Fresenius Medical Care delivers strong 2016 results and sets ambitious growth targets for 2017 52
Dec 01, 2016: Fresenius Medical Care will focus on IFRS reporting and discontinue U.S. GAAP financial statements 55
Oct 27, 2016: Fresenius Medical Care reports strong third quarter and confirms full year guidance 56
May 03, 2016: Fresenius Medical Care reports strong start to the year 2016 59
Feb 24, 2016: Fresenius Medical Care reports fourth quarter and full year 2015 results 61
Corporate Communications 64
Dec 02, 2016: Change in Investor Relations Management – Dr. Dominik Heger joins Fresenius Medical Care 64
May 12, 2016: Fresenius Medical Care expects continued, strong growth – Annual General Meeting approves 19th consecutive dividend increase 65
Mar 11, 2016: Fresenius Medical Care announces proposals for election to the Supervisory Board by the Annual General Meeting on May 12, 2016 66
Jan 28, 2016: Fresenius Medical Care announces change in Management Board 67
Legal and Regulatory 68
Jan 13, 2017: Statement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order 68
Feb 17, 2016: Fresenius Medical Care reaches agreement in principle to resolve the GranuFlo/NaturaLyte product liability litigation 69
Product News 70
Nov 17, 2016: Fresenius Medical Care Showcases Breadth and Depth of Clinical Research with Nearly 70 Abstracts Slated for Presentation at the American Society of Nephrology 2016 Kidney Week Meeting 70
Other Significant Developments 72
Jun 21, 2016: Fresenius Medical Care North America Significantly Reduces Mortality and Hospitalization for Dialysis Patients 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73

List of Tables
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Key Facts, 2016 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Fresenius Medical Care AG & Co KGaA, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Fresenius Medical Care AG & Co KGaA, Deals By Market, 2011 to YTD 2017 9
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 12
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 14
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 15
Debiotech and Fresenius Medical Care Enter into Agreement 16
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 17
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 18
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 19
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 20
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 21
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 22
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 23
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 25
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 26
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 27
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 28
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 29
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 30
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 31
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 32
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 33
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 34
Fresenius Medical Care to Acquire NxStage Medical for up to USD2 Billion 35
Fresenius Medical Care Acquires Xenios 37
Fresenius Medical Care to Acquire Nefrocontrol 38
Fresenius Medical Care AG & Co KGaA, Key Competitors 39
Fresenius Medical Care AG & Co KGaA, Key Employees 40
Fresenius Medical Care AG & Co KGaA, Subsidiaries 41
Fresenius Medical Care AG & Co KGaA, Joint Venture 44

★海外企業調査レポート[Fresenius Medical Care AG & Co KGaA (FMS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Feldan Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Feldan Therapeutics Inc (Feldan), formerly Feldan Bio Inc, is a biotechnology company with focus on the discovery, development, manufacture and marketing of recombinant proteins. The company developed a peptide-based technology platform, the Feldan Shuttle for intracellular delivery of prote …
  • Cogent Communications Holdings inc (CCOI):企業の財務・戦略的SWOT分析
    Cogent Communications Holdings inc (CCOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Dampier Gold Limited:企業の戦略・SWOT・財務分析
    Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report Summary Dampier Gold Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Stockland Corporation Ltd:企業の戦略・SWOT・財務情報
    Stockland Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Stockland Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • SM Prime Holdings, Inc.:企業の戦略・SWOT・財務情報
    SM Prime Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary SM Prime Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Calpine Corporation (CPN)-エネルギー分野:企業M&A・提携分析
    Summary Calpine Corporation (Calpine) is an electric and natural gas utility. The company produces electricity and thermal energy from natural gas, geothermal, and solar sources. It uses natural gas-fired combustion and renewable geothermal conventional steam turbine technologies to generate energy. …
  • Nila Infrastructures Ltd:企業の戦略・SWOT・財務分析
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CooperVision Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Landesbank Hessen Thueringen Girozentrale:企業の戦略・SWOT・財務情報
    Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report Summary Landesbank Hessen Thueringen Girozentrale - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Nabors Industries Ltd.:戦略・SWOT・企業財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Optimum General Inc.
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Weir Group Plc (WEIR):石油・ガス:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Siemens Healthineers.:企業のM&A・事業提携・投資動向
    Siemens Healthineers. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Healthineers. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BASF Corp-エネルギー分野:企業M&A・提携分析
    Summary BASF Corp (BASF), a subsidiary of BASF SE, is a chemical manufacturing company. Its product portfolio includes petrochemicals, monomers, intermediates, dispersions and pigments, care chemicals, nutrition and health products, paper chemicals, performance chemicals, catalysts, construction che …
  • Bionure Farma SL-製薬・医療分野:企業M&A・提携分析
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its …
  • NeuroVive Pharmaceutical AB (NVP):企業の財務・戦略的SWOT分析
    Summary NeuroVive Pharmaceutical AB (NeuroVive), formerly NeuroPharma i Sverige AB focuses on the research and development of mitochondrial therapies. The company’s programs include NeuroSTAT, a clinical phase II drug candidate for the prevention of traumatic brain injury; and phase I KL1333, a nove …
  • Hammond Power Solutions Inc (HPS.A):企業の財務・戦略的SWOT分析
    Hammond Power Solutions Inc (HPS.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Chronos Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Chronos Therapeutics Ltd (Chronos) is a developer of medications for degenerative and behavioural diseases of the brain and nervous system. The company offers research and development, screening, discovery, repositioning and acquisition programs. Its pipeline products comprise RDC5 neurodege …
  • Avon Products, Inc.:企業の戦略・SWOT・財務情報
    Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avon Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆